Microdose ophthalmic spray offers a noninferior, more comfortable alternative to traditional eye drops for pediatric pupillary dilation.

Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarterFY 2025 net revenue of $106.5 million, driven by growth in MIPLYFFA® ...

Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD), announced at the MDA (Muscular Dystrophy ...

Discover the emotional ending of Stumble season 1 episode 12 as Coach Courteney makes the ultimate sacrifice. Read the detailed recap to learn why Madonna was cut, how the squad reacted, and the ...

Rocket Pharmaceuticals, Inc. ( RCKT) TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM EST ...

As of Friday, March 06, Solid Biosciences Inc.’s SLDB share price has surged by 13.19%, which has investors questioning if this is right time to sell.

Scientists created half-Möbius molecules, similar to the Möbius strips common in math classes, but half as twisty. It’s a ...

A resurrected ancient enzyme is helping scientists test how reliably Earth’s oldest rocks record signs of life.

Liam Neeson's son Daniel Neeson revealed on social media that he underwent surgery to treat a severe left ventricle dilation ...

AFTX-201 is designed using Affinia's proprietary capsid engineered for efficient cardiac transduction at doses that are 5-10-fold lower than doses of gene therapies using conventional capsids WALTHAM, ...

Eton Pharmaceuticals. Eton Pharmaceuticals expands rare disease portfolio through acquisition of U.S. commercialization rights to HEMANGEOL® (propranolol hydrochloride) oral solution. Eton ...

AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.